Slovakia - slovakki - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

genera, chorvátsko - lyof.

Euroopan unioni - slovakki - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastické činidlá - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Euroopan unioni - slovakki - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Slovakia - slovakki - myHealthbox

bayer ag - olejová disperzia - foramsulfuron 50 g/l; thiencarbazone-methyl 30 g/l

Slovakia - slovakki - myHealthbox

bayer ag - olejová disperzia - foramsulfuron 50 g/l; thiencarbazone-methyl 30 g/l

Slovakia - slovakki - myHealthbox

bayer ag - dispergovateľný koncentrát - fluopyram 200 g/l; tebuconazole 200 g/l

Slovakia - slovakki - myHealthbox

bayer ag - dispergovateľný koncentrát - fluopyram 200 g/l; tebuconazole 200 g/l

Euroopan unioni - slovakki - EMA (European Medicines Agency)

sanofi b.v. - laronidáza - mucopolysacharidóza i - iné alimentárny trakt a metabolizmus výrobky, - aldurazyme je určený pre dlhodobé enzým substitučná terapia u pacientov s potvrdená diagnóza mucopolysaccharidosis i (mps i, alfa-l-iduronidase nedostatok) na liečbu nonneurological prejavy ochorenia.